C07D 473/20
Two sulfur atoms
Official title: two sulfur atoms
C07D473/20 (Two sulfur atoms) appears on 19 US grants and 5 published applications in this corpus.
Search patents in C07D- Granted patents
- 19
- Published applications
- 5
- Assignees
- 11
- Inventors
- 39
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Small molecule PARG inhibitors and methods of use thereof9 Dec 2025US 12,491,188 B2Board of Regents, The University of Texas System
- Thioxanthine derivatives and their use as inhibitors of MPO27 Sep 2011US 8,026,244 B2AstraZeneca AB
- Processes for preparing 1,3-dioxolane nucleosides15 Feb 2005US 6,855,821 B2Pharmasset, Inc.
- Purine derivatives having phosphodiesterase iv inhibition activity2 Jul 2002US 6,413,975 B1Euro-Celtique S. A.
- Purine derivatives having phosphodiesterase IV inhibition activity20 Nov 2001US 6,319,928 B1Euro-Celtique S. A.
- Small molecule parg inhibitors and methods of use thereof30 Jun 2022US 2022/0202821 A1Board of Regents, The University of Texas System
- Thioxanthine Derivatives and Their Use as Inhibitors of MPO19 Nov 2009US 2009/0286813 A1AstraZeneca AB
- Thioxanthine Derivatives and Their Use as Inhibitors of MPO11 Jun 2009US 2009/0149475 A1AstraZeneca AB
- Processes for preparing 1,3-dioxolane nucleosides6 May 2004US 2004/0087806 A1Pharmasset, Inc.
- Purine compounds having PDE IV inhibitory activity and methods of synthesis17 Apr 2003US 2003/0073834 A1
Most cited
By later US patents
- Xanthine derivatives50US 4,879,296 ABurroughs Wellcome Co. · 1989
- Heterocyclic compounds, their production and use42US 5,753,664 ATakeda Chemical Industries, Ltd. · 1998
- Acetal-and ketal-substituted pyrimidine compounds30US 5,777,115 ACell Therapeutics, Inc. · 1998
- Xanthine derivatives28US 5,290,782 AKyowa Hakko Kogyo Co., Ltd. · 1994
- Purine Derivatives21US 4,981,857 ABurroughs Wellcome Co. · 1991